UnitedHealth raised 2026 outlook. UnitedHealth Group stock falls 1.68 percent.

Published on 10/16/2026 at 09:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 2026 adjusted earnings reached USD 4.69. UnitedHealth Group stock costs EUR 362.40 on October 16, 2026, 1.68 percent below the EUR 368.60 Xetra close.

Third-quarter earnings and valuation

UnitedHealth Group reported USD 112.70 billion in third-quarter 2026 revenue on October 13, 2026.
The medical care ratio improved to 88.40 percent from 89.90 percent in the third quarter of 2025.
UnitedHealth Group stock trades at EUR 362.40 at 9:10 a.m. CEST at Lang & Schwarz on October 16, 2026, 1.68 percent below the Xetra close of October 15, 2026.
Market capitalization stood at EUR 330.9 billion as of October 15, 2026.

Schwarz-Weiß-Reportage: Arzt in Telemedizin-Beratung per Laptop mit Patientin auf Bildschirm — UnitedHealth Group US91324P1021 zeigt Arzt bei digitaler Telemedizin-Konsultation per Laptop in Schwarz-Weiß, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) was trading at EUR 362.40 at Lang & Schwarz on October 16, 2026 at 9:10 a.m. CEST, down 1.68 percent versus the Xetra close of October 15, 2026 at EUR 368.60. The move followed the company's October 13, 2026 report that raised its full-year adjusted earnings outlook to at least USD 20.50 per share, according to UnitedHealth Group.

Results improved on lower costs

Third-quarter revenue reached USD 112.70 billion, versus USD 113.20 billion in the year-ago quarter, while earnings from operations rose to USD 6.60 billion from USD 4.30 billion. Adjusted earnings per share came in at USD 4.69, above the USD 4.14 consensus estimate cited by CNBC.

The earnings improvement was accompanied by a lower medical care ratio. The measure was 88.40 percent in the third quarter of 2026, compared with 89.90 percent a year earlier, while UnitedHealthcare revenue declined to USD 86.30 billion from USD 87.10 billion.

What does the margin recovery mean?

The figures point to better cost control, but they also show why revenue quality matters. Reuters reported on October 13, 2026 that the company linked the improvement to plan design, pricing and medical cost controls. Reuters also reported that 935,000 members had exited the Medicare Advantage business since the end of 2025.

Three milestones set the path

On August 12, 2026, the board authorized a quarterly dividend, according to UnitedHealth Group. On September 15, 2026, the company announced October 13, 2026 as its earnings release date. On October 13, 2026, it reported USD 112.70 billion in quarterly revenue and raised its adjusted earnings outlook to at least USD 20.50 per share.

Stock valuation stays measurable

UnitedHealth Group had a market capitalization of EUR 330.9 billion as of October 15, 2026. Its 52-week range was EUR 222.70 to EUR 400.60, placing the current euro quote EUR 38.20 below the high and EUR 139.70 above the low.

Stock price and investor perspective

The immediate market question is whether improved margins can offset lower membership and revenue in parts of the insurance business. The current euro quote remains below the Xetra close of October 15, 2026.

UnitedHealth Group was trading at EUR 362.40 at Lang & Schwarz on October 16, 2026 at 9:10 a.m. CEST, 1.68 percent below the Xetra close of October 15, 2026 at EUR 368.60. The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.